News & Blog

Amphastar Intranasal Naloxone Delay

Amphastar Naloxone Intranasal Approval In a disappointing press release issued February 21, 2017, pharmaceutical company Amphastar announced that its New Drug Application for Intranasal Naloxone received a Complete Response Letter from the U.S. Food and Drug...

read more

© 2018 ResQ Pharma, Inc.